Hepatitis B Virus (HBV)

CAS No.	Product Name	Inquiry
142217-81-0	3',5'-Di-O-benzyl Entecavir A derivative of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body.
1428729-63-8	RIG-1 modulator 1 RIG-1 modulator 1 is an inhibitor of HBV, HCV and HIV.
143188-53-8	Lamivudine Triphosphate 3TCTP is a dideoxynucleoside analog and an inhibitor of reverse transcriptase that exhibit antiviral effect in vivo.
14365-45-8	2'-Deoxy-L-adenosine A useful synthon for modified oligodeoxyribonucleotides.
1445790-55-5	NVR-3-778 NVR 3-778 is a first-in-Class and oral bioavailable HBV CAM (capsid assembly modulator) belonging to the SBA(sulfamoylbenzamide) class, with anti-HBV activity.
1446486-33-4	Tenofovir Disoproxil USP Related Compound B Tenofovir Disoproxil USP Related Compound B is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS.
147127-19-3	(S)-Tenofovir One isomer impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor.
148717-90-2	Squalamine Squalamine is a naturally derived broad-spectrum antibiotic that is predominantly derived from the livers of dogfish and other shark species. Squalamine is undergoing trials for treatment of non-small cell lung cancer (stage I/IIA) as well as general phase I pharmacokinetic studies. In 2005, the Food and Drug Administration granted squalamine Fast Track status for approval for treatment of age-related macular degeneration. However, the Genaera Corporation, the company that has done the most work with squalamine, discontinued trials for its use in treating prostate cancer and wet age-related macular degeneration in 2007. The Squalamine project was acquired by Ohr Pharmaceutical from the now liquidated Genaera, with the prospect of continuing the development of this drug to treat wet age-related macular degeneration.
150132-22-2	(-)-5′-Noraristeromycin
1571076-15-7	(1R)-Tenofovir-amibufenamide (1R)-Tenofovir amibufenamide ((1R)-HS-10234) is the isomer of Tenofovir amibufenamide, is an orally active antiviral agent. Tenofovir amibufenamide inhibits HBV, and can be used for chronic hepatitis B (CHB) study.
1571076-26-0	Tenofovir amibufenamide Tenofovir amibufenamide, a prodrug of Tenofovir, is an orally active antiviral agent. It inhibits HBV and can be used in the study of chronic hepatitis B (CHB).
1572510-42-9	JNJ-632 JNJ-632 is a modulator of hepatitis B virus (HBV) capsid assembly. It induces the formation of morphologically intact viral capsids, as demonstrated by size exclusion chromatography and electron microscopy studies.
1572510-80-5	AB-423 AB-423 is an inhibitor of HBV capsid assembly, and potent inhibits HBV replication with EC50/EC90 of 0.08-0.27 μM/0.33-1.32 μM in cells.
1578153-27-1	RO6889678 RO6889678 is a highly potent HBV capsid formation inhibitor with a complex absorption, distribution, metabolism, and excretion (ADME) profile. RO6889678 is a potent inducer of CYP3A4 and coregulated proteins in human hepatocytes.
1638266-40-6	Bersacapavir Bersacapavir is an assembly modulator of hepatitis B virus capsid.
173522-96-8	Lamivudine Salicylate Lamivudine Salicylate is used in the synthesis of Lamivudine, which is a potent nucleoside reverse transcriptase inhibitor and antiviral agent used to treat chronic hepatitis B.
174625-00-4	Clevudine triphosphate
1793063-59-8	HEC72702
1834483-86-1	Hbv-IN-38
193681-12-8	Alamifovir

※ Please kindly note that our services are for research use only.